HUP0102116A3 - Paroxetine ascorbate, process for its preparation and its pharmaceutical use - Google Patents
Paroxetine ascorbate, process for its preparation and its pharmaceutical useInfo
- Publication number
- HUP0102116A3 HUP0102116A3 HU0102116A HUP0102116A HUP0102116A3 HU P0102116 A3 HUP0102116 A3 HU P0102116A3 HU 0102116 A HU0102116 A HU 0102116A HU P0102116 A HUP0102116 A HU P0102116A HU P0102116 A3 HUP0102116 A3 HU P0102116A3
- Authority
- HU
- Hungary
- Prior art keywords
- preparation
- pharmaceutical use
- paroxetine ascorbate
- paroxetine
- ascorbate
- Prior art date
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title 2
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title 1
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title 1
- 229940072107 ascorbate Drugs 0.000 title 1
- 235000010323 ascorbic acid Nutrition 0.000 title 1
- 239000011668 ascorbic acid Substances 0.000 title 1
- 229960002296 paroxetine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9808896.6A GB9808896D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0102116A2 HUP0102116A2 (hu) | 2002-05-29 |
| HUP0102116A3 true HUP0102116A3 (en) | 2002-12-28 |
Family
ID=10831008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0102116A HUP0102116A3 (en) | 1998-04-25 | 1999-04-23 | Paroxetine ascorbate, process for its preparation and its pharmaceutical use |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1089995A1 (tr) |
| JP (1) | JP2002513019A (tr) |
| KR (1) | KR20010042977A (tr) |
| CN (1) | CN1297448A (tr) |
| AP (1) | AP2000001963A0 (tr) |
| AU (1) | AU3618499A (tr) |
| BG (1) | BG104940A (tr) |
| BR (1) | BR9909868A (tr) |
| CA (1) | CA2330055A1 (tr) |
| EA (1) | EA200001104A1 (tr) |
| GB (1) | GB9808896D0 (tr) |
| HU (1) | HUP0102116A3 (tr) |
| ID (2) | ID26083A (tr) |
| IL (1) | IL139081A0 (tr) |
| NO (1) | NO20005352D0 (tr) |
| PL (1) | PL343677A1 (tr) |
| SK (1) | SK15912000A3 (tr) |
| TR (1) | TR200003084T2 (tr) |
| WO (1) | WO1999055698A1 (tr) |
| ZA (1) | ZA200005912B (tr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
| IL159280A0 (en) * | 2001-06-14 | 2004-06-01 | Teva Pharma | A process for preparing paroxetine hcl which limits formation of pink colored compounds |
| EP1469827B1 (en) | 2002-01-09 | 2017-12-27 | Emisphere Technologies, Inc. | Polymorphs of sodium 4- (4-chloro-2-hydroxybenzoyl)amino butanoate |
| CN110607553B (zh) * | 2018-10-30 | 2024-03-22 | 中国科学院化学研究所 | 一种制备粒径可调的药物或药物中间体单晶或无定型物的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| ES2058061T3 (es) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
| US5276042A (en) * | 1993-04-16 | 1994-01-04 | Crenshaw Roger T | Treatment of premature ejaculation |
| ES2117557B1 (es) * | 1996-02-29 | 1999-07-01 | Ferrer Int | Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina. |
-
1998
- 1998-04-25 GB GBGB9808896.6A patent/GB9808896D0/en not_active Ceased
-
1999
- 1999-04-23 SK SK1591-2000A patent/SK15912000A3/sk unknown
- 1999-04-23 AU AU36184/99A patent/AU3618499A/en not_active Abandoned
- 1999-04-23 KR KR1020007011809A patent/KR20010042977A/ko not_active Application Discontinuation
- 1999-04-23 WO PCT/GB1999/001244 patent/WO1999055698A1/en not_active Application Discontinuation
- 1999-04-23 ID IDW20002168A patent/ID26083A/id unknown
- 1999-04-23 BR BR9909868-7A patent/BR9909868A/pt not_active Application Discontinuation
- 1999-04-23 EA EA200001104A patent/EA200001104A1/ru unknown
- 1999-04-23 TR TR2000/03084T patent/TR200003084T2/tr unknown
- 1999-04-23 CN CN99805160A patent/CN1297448A/zh active Pending
- 1999-04-23 PL PL99343677A patent/PL343677A1/xx not_active Application Discontinuation
- 1999-04-23 IL IL13908199A patent/IL139081A0/xx unknown
- 1999-04-23 CA CA002330055A patent/CA2330055A1/en not_active Abandoned
- 1999-04-23 AP APAP/P/2000/001963A patent/AP2000001963A0/en unknown
- 1999-04-23 JP JP2000545858A patent/JP2002513019A/ja active Pending
- 1999-04-23 ID IDW20002169A patent/ID26654A/id unknown
- 1999-04-23 EP EP99918151A patent/EP1089995A1/en not_active Withdrawn
- 1999-04-23 HU HU0102116A patent/HUP0102116A3/hu unknown
-
2000
- 2000-10-23 ZA ZA200005912A patent/ZA200005912B/en unknown
- 2000-10-24 NO NO20005352A patent/NO20005352D0/no not_active Application Discontinuation
- 2000-11-13 BG BG104940A patent/BG104940A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR200003084T2 (tr) | 2001-02-21 |
| EA200001104A1 (ru) | 2001-04-23 |
| EP1089995A1 (en) | 2001-04-11 |
| ID26083A (id) | 2000-11-23 |
| ID26654A (id) | 2001-01-25 |
| SK15912000A3 (sk) | 2001-04-09 |
| BG104940A (bg) | 2001-09-28 |
| AU3618499A (en) | 1999-11-16 |
| BR9909868A (pt) | 2000-12-19 |
| ZA200005912B (en) | 2001-12-19 |
| IL139081A0 (en) | 2001-11-25 |
| KR20010042977A (ko) | 2001-05-25 |
| NO20005352L (no) | 2000-10-24 |
| CA2330055A1 (en) | 1999-11-04 |
| NO20005352D0 (no) | 2000-10-24 |
| JP2002513019A (ja) | 2002-05-08 |
| CN1297448A (zh) | 2001-05-30 |
| WO1999055698A1 (en) | 1999-11-04 |
| GB9808896D0 (en) | 1998-06-24 |
| HUP0102116A2 (hu) | 2002-05-29 |
| AP2000001963A0 (en) | 2000-12-31 |
| PL343677A1 (en) | 2001-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0105414A3 (en) | Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them | |
| PL346530A1 (en) | Azetidine derivatives, preparation and medicines containing them | |
| HUP0100431A3 (en) | Adamantana derivatives, pharmaceutical compositions comprising them and process for preparing them | |
| IL141769A0 (en) | Azetidine derivatives, preparation and medicines containing them | |
| HUP0105478A2 (en) | 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use | |
| HUP0203316A3 (en) | Amino-triazolopyridine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0001555A3 (en) | Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation | |
| HUP0004747A3 (en) | 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline derivatives and process for their preparation | |
| HUP0201516A3 (en) | 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0102292A3 (en) | Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use | |
| HUP0201753A2 (en) | Pyridopyranoazepine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0301333A3 (en) | Pharmaceutical superdisintegrant, process for its preparation and its use | |
| HUP0201402A3 (en) | Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them | |
| HUP0203184A3 (en) | Isoxazolecarboxamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0202731A3 (en) | O-anisamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
| IL180579A0 (en) | Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them | |
| HUP0104620A3 (en) | 2-phenylpyran-4-one derivatives, process for their preparation and medicaments containing them | |
| HUP0101234A3 (en) | Betha-carboline derivatives, process for their preparation and pharmaceutical compositions thereof | |
| HUP0104819A2 (en) | Chroman derivatives, their use intermediate and process for their preparation | |
| HUP0103712A3 (en) | Salts of paroxetine, process for their preparation and their pharmaceutical use | |
| HUP0103651A2 (en) | Paroxetine maleate and process for its preparation | |
| HUP0102116A3 (en) | Paroxetine ascorbate, process for its preparation and its pharmaceutical use | |
| HUP0200376A3 (en) | Thiaoloindolinone compounds, process for their preparation and pharmaceutical composions containing them and their use | |
| GR3035834T3 (en) | Benzoxazindione derivatives, process for their preparation and their use | |
| HUP0203468A3 (en) | Betha-d-5-thioxylose derivatives, preparation method and therapeutic use thereof |